Fresenius SE & Co KGaA/ DE0005785604 /
8/11/2022 4:53:14 PM | Chg. -0.01 | Volume | Bid5:30:00 PM | Ask5:30:00 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
24.75EUR | -0.02% | 920 Turnover: 22,763.12 |
-Bid Size: - | -Ask Size: - | 13.83 bill.EUR | 3.72% | 7.60 |
GlobeNewswire
6/11/2021
UPDATE -- Humacyte Expands Strategic Global Partnership with Fresenius Medical Care
GlobeNewswire
2/4/2021
Cove Capital Acquires Fresenius Medical Care Dialysis Facility in New Orleans
GlobeNewswire
11/11/2019
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fresenius Medica...
GlobeNewswire
11/4/2019
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fresenius Medica...
GlobeNewswire
10/29/2019
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Fresenius Medica...
GlobeNewswire
10/23/2019
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fresenius Medic...
GlobeNewswire
7/16/2018
OPKO Partner Vifor Fresenius Receives Marketing Approval for RAYALDEE in Canada
GlobeNewswire
2/21/2018
Global Kidney Dialysis Equipment and Supplies Markets 2016-2024: Fresenius and Baxter Dominate the M...
GlobeNewswire
6/9/2017
KISSEI TO MARKET AVACOPAN IN JAPAN FOR VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA
GlobeNewswire
1/27/2011
Swedish Orphan Biovitrum agrees with Fresenius Biotech to distribute Removab®